Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Regulators back Novartis’ Votubia

June 28, 2011 Sales and Marketing Novartis, Votubia, everolimus

Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
News

Service Insight: Submission development and market access

June 28, 2011 Sales and Marketing Service Insight

SERVICE INSIGHT A successful health technology assessment is critical for market access in the UK. However, submissions that don’t follow …
Feature

Sanofi appoints Peter Guenter senior VP, Europe

June 28, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
Appointment

Activaero appoints Christian Pangratz

June 27, 2011 Sales and Marketing appointment, sales and marketing

Activaero GmbH has appointed Christian Pangratz as chief business officer, with a brief to lead its business development, marketing and …
Appointment

CHMP backs Boehringer-Lilly diabetes drug Trajenta

June 27, 2011 Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been recommended for European approval. It was given …
News

Beyond technology: how pharma marketing will be transformed…..

June 27, 2011 Medical Communications, Sales and Marketing digital marketing, pharma marketing

I speak about social media and pharma company communications all the time. I find myself talking about it not just …
Feature

Service Insight: Keeping up with changes in the NHS

June 23, 2011 Sales and Marketing Service Insight

SERVICE INSIGHT
Feature

Merck scraps MS pill cladribine

June 23, 2011 Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis

Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …
News

AstraZeneca sells off dental business for $1.8bn

June 23, 2011 Sales and Marketing AstraZeneca, strategy

AstraZeneca is to sell its dental products firm Astra Tech to DENTSPLY for $1.8 billion. Astra Tech comprises two business …
News

European approval for BMS kidney transplant drug Nulojix

June 22, 2011 Sales and Marketing BMS, EMA, Nulojix, transplant

European regulators have followed their US counterparts in granting marketing authorisation for a drug which aims to prevent kidney transplant …
News

FDA approves Pfizer pain drug Oxecta

June 21, 2011 Sales and Marketing FDA, Oxecta, Pfizer, chronic pain

The FDA has approved Pfizer and Acura’s novel pain drug Oxecta, but will require follow up studies to prove its …
News

NICE gains expanded role alongside value-based pricing

June 21, 2011 Sales and Marketing NHS reforms, NICE, value-based pricing

NICE will be given a wider remit to oversee social care and its guidance used alongside value-based pricing as part …
News

NICE backs Celgene’s thalidomide and Janssen’s Velcade

June 21, 2011 Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s thalidomide and Janssen-Cilag’s Velcade have been given the thumbs up by NICE as a treatment for a cancer that …
News

NICE reprieved by government U-turn

June 20, 2011 Sales and Marketing Health and Social Care Bill, NICE, value-based pricing

The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …
News

Double Helix appoints Sarah Frere-Cook and Ginevra Drinka

June 20, 2011 Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

Double Helix has boosted its London-based strategic market research team with two new appointments. Sarah Frere-Cook joins as a research …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026